Mission and Leadership of Vir Biotechnology
Vir’s core capabilities include our deep immunology and virology expertise, our proven world-class monoclonal antibody platform with AI-led protein engineering capabilities, as well as our T cell-based viral vector platform. Vir has built a broad pipeline with several ongoing trials – including two late-stage programs in chronic hepatitis delta and chronic hepatitis B – that we believe will support near- and long-term growth, along with multiple potential INDs in the next 12-24 months. If you share our goal of addressing the unmet needs of patients around the world, please visit our careers page for open positions. Our growth and pursuit of scientific innovation is fueled by our leading monoclonal antibody (mAb) platform that has a proven track record and is further strengthened by our artificial intelligence-led mAb optimization and engineering capabilities. Our ability to develop impactful medicines for major public health challenges is a testament to the company’s deep knowledge of immunology and our ability to understand the interplay between viruses and the human immune system.”. We have an industry-leading management team and Board of Directors with significant immunology and infectious diseases experience, including a proven track record of progressing product candidates from early-stage research through clinical development, and worldwide regulatory approval and commercialization. We offer the opportunity to do challenging, rewarding work as part of our world class teams in the U.S.
Keywords
Industries
Where is Vir Biotechnology located?
The company Vir Biotechnology is located in San Francisco, California, United States. It's worth noting that the company may has more corporate locations
How many employees does Vir Biotechnology approximately have?
As of the latest available information Vir Biotechnology has around 101-250 employees worldwide.
When was Vir Biotechnology founded?
Vir Biotechnology was founded in 2016
In which industries does Vir Biotechnology mainly work?
The company Vir Biotechnology has it's main focus in the industries of Science and Engineering, Biotechnology, Health Care
What is the current company status of Vir Biotechnology?
Based on the founding year and the amount of employees the company Vir Biotechnology seems to be a Medium-Sized Company at the current state. Note that over time that status can change
Vira Therapeutics
Austria
11-50 Employees
2015
Virica Biotech
Canada
11-50 Employees
2018
ImmVirX
Australia
11-50 Employees
2019
Virogin Biotech
Canada
11-50 Employees
2015
VBI Vaccines
United States
101-250 Employees
2001
Virovet
Belgium
11-50 Employees
2015
Via Nova Therapeutics
United States
2020
Virovax Limited
United Kingdom
1-10 Employees
2016
Topics which have been searched by others and may be interesting for you: